4//SEC Filing
Johnson Brady 4
Accession 0001209191-22-002602
CIK 0001610618other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 8:23 PM ET
Size
9.6 KB
Accession
0001209191-22-002602
Insider Transaction Report
Form 4
Johnson Brady
Dir. of Finance & Controller
Transactions
- Exercise/Conversion
Common Stock
2021-12-29+262→ 51,381 total - Exercise/Conversion
Restricted Stock Unit
2021-12-29−262→ 262 totalExp: 2027-09-17→ Common Stock (262 underlying) - Sale
Common Stock
2022-01-05$1.25/sh−416$520→ 50,965 total
Footnotes (5)
- [F1]The Reporting Person was previously granted restricted stock units to vest upon the achievement of certain milestone events that occurred on December 29, 2021.
- [F2]Includes 4,000 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 19, 2021.
- [F3]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on December 29, 2021 and January 1, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F4]Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer.
- [F5]On January 31, 2019, the Reporting Person was granted RSUs totaling 787 shares subject to vesting upon the achievement of various milestones.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001751478
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 8:23 PM ET
- Size
- 9.6 KB